These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29981416)

  • 1. Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer.
    Jiang M; Xiao Y; Liu D; Luo N; Gao Q; Guan Y
    Gene; 2018 Oct; 675():217-224. PubMed ID: 29981416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
    Yuan Q; Zhang Y; Feng L; Jiang Y
    J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
    Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
    Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LINC01296 is a potential prognostic biomarker in patients with colorectal cancer.
    Qiu JJ; Yan JB
    Tumour Biol; 2015 Sep; 36(9):7175-83. PubMed ID: 25894381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long intergenic noncoding RNA 01296 aggravates gastric cancer cells progress through miR-122/MMP-9.
    Qin QH; Yin ZQ; Li Y; Wang BG; Zhang MF
    Biomed Pharmacother; 2018 Jan; 97():450-457. PubMed ID: 29091895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer.
    Seitz AK; Christensen LL; Christensen E; Faarkrog K; Ostenfeld MS; Hedegaard J; Nordentoft I; Nielsen MM; Palmfeldt J; Thomson M; Jensen MT; Nawroth R; Maurer T; Ørntoft TF; Jensen JB; Damgaard CK; Dyrskjøt L
    Sci Rep; 2017 Mar; 7(1):395. PubMed ID: 28341852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA LINC01296 regulates the proliferation, metastasis and cell cycle of osteosarcoma through cyclin D1.
    Yu X; Pang L; Yang T; Liu P
    Oncol Rep; 2018 Nov; 40(5):2507-2514. PubMed ID: 30226542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between lncRNA LINC01296 and the clinical characteristics in neuroblastoma.
    Wang J; Wang Z; Yao W; Dong K; Zheng S; Li K
    J Pediatr Surg; 2019 Dec; 54(12):2589-2594. PubMed ID: 31522796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
    Deng X; Zhao Y; Wu X; Song G
    Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis.
    Wu J; Cheng G; Zhang C; Zheng Y; Xu H; Yang H; Hua L
    Onco Targets Ther; 2017; 10():1843-1852. PubMed ID: 28392705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma.
    Zhang D; Li H; Xie J; Jiang D; Cao L; Yang X; Xue P; Jiang X
    Int J Oncol; 2018 Jun; 52(6):1777-1786. PubMed ID: 29620172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
    Peng W; Wu G; Fan H; Wu J; Feng J
    Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA LINC01296 plays an oncogenic role in colorectal cancer by suppressing p15 expression.
    Xu J; Zhang Z; Shen D; Zhang T; Zhang J; De W
    J Int Med Res; 2021 May; 49(5):3000605211004414. PubMed ID: 33983053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
    Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y
    Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA LINC01296 acts as a migration and invasion promoter in head and neck squamous cell carcinoma and predicts poor prognosis.
    Wu J; Chen H; Li J; Li X; Cao J; Qi M
    Bioengineered; 2021 Dec; 12(1):5607-5619. PubMed ID: 34515611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
    Han L; Ma P; Liu SM; Zhou X
    Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of LINC01296 Expression in Patients with Cancer: A Systematic Review and Meta-Analysis.
    Saeidi F; Tanha K; Davoodabadi Farahani M; Sohrabi E; Moradi Y; Khani P
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2189-2195. PubMed ID: 32856843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of long noncoding RNA CASC2 indicates a poor prognosis and promotes tumorigenesis in thyroid carcinoma.
    Xiong X; Zhu H; Chen X
    Biomed Pharmacother; 2017 Sep; 93():391-397. PubMed ID: 28654795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of long non-coding RNA 01296 expression in human solid malignant tumours: a meta-analysis.
    Dai C; Dai C; Ni H; Xu Z
    Postgrad Med J; 2020 Jan; 96(1131):43-52. PubMed ID: 31444240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.